0001209191-23-044683.txt : 20230804
0001209191-23-044683.hdr.sgml : 20230804
20230804185423
ACCESSION NUMBER: 0001209191-23-044683
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230802
FILED AS OF DATE: 20230804
DATE AS OF CHANGE: 20230804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gould Stephen E
CENTRAL INDEX KEY: 0001934498
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38935
FILM NUMBER: 231145288
MAIL ADDRESS:
STREET 1: C/O ATRECA, INC.
STREET 2: 835 INDUSTRIAL ROAD, SUITE 400
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atreca, Inc.
CENTRAL INDEX KEY: 0001532346
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273723255
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 835 INDUSTRIAL ROAD,
STREET 2: SUITE 400
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-595-2595
MAIL ADDRESS:
STREET 1: 835 INDUSTRIAL ROAD,
STREET 2: SUITE 400
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-02
0
0001532346
Atreca, Inc.
BCEL
0001934498
Gould Stephen E
835 INDUSTRIAL ROAD, SUITE 400
SAN CARLOS
CA
94070
0
1
0
0
Chief Scientific Officer
0
Class A Common Stock
2023-08-02
4
S
0
4076
0.9522
D
28424
D
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" and does not represent a discretionary trade by the Reporting Person.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.92 to
$0.97 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the
Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the
range set forth in this footnote.
/s/ Courtney Phillips, Attorney-In-Fact
2023-08-04